Delta-Fly Pharma, Inc. (4598.T)

JPY 460.0

(-7.26%)

Total Assets Summary of Delta-Fly Pharma, Inc.

  • Delta-Fly Pharma, Inc.'s latest annual total assets in 2023 was 1.47 Billion JPY , up 62.56% from previous year.
  • Delta-Fly Pharma, Inc.'s latest quarterly total assets in 2024 Q1 was 827 Million JPY , down -13.18% from previous quarter.
  • Delta-Fly Pharma, Inc. reported annual total assets of 906.81 Million JPY in 2022, down -31.53% from previous year.
  • Delta-Fly Pharma, Inc. reported annual total assets of 1.32 Billion JPY in 2021, down -38.72% from previous year.
  • Delta-Fly Pharma, Inc. reported quarterly total assets of 1.47 Billion JPY for 2023 Q4, down -17.19% from previous quarter.
  • Delta-Fly Pharma, Inc. reported quarterly total assets of 1.78 Billion JPY for 2023 Q3, up 262.72% from previous quarter.

Annual Total Assets Chart of Delta-Fly Pharma, Inc. (2023 - 2019)

Historical Annual Total Assets of Delta-Fly Pharma, Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 1.47 Billion JPY 62.56%
2022 906.81 Million JPY -31.53%
2021 1.32 Billion JPY -38.72%
2020 2.16 Billion JPY -0.04%
2019 2.16 Billion JPY 0.0%

Peer Total Assets Comparison of Delta-Fly Pharma, Inc.

Name Total Assets Total Assets Difference
KOHJIN BIO CO LTD 6.58 Billion JPY 77.628%
PRISM BioLab Co.,LTD 1.21 Billion JPY -21.688%
GNI Group Ltd. 62.39 Billion JPY 97.637%
Linical Co., Ltd. 18.53 Billion JPY 92.049%
Trans Genic Inc. 9.81 Billion JPY 84.974%
MEDINET Co., Ltd. 5.63 Billion JPY 73.835%
Soiken Holdings Inc. 6.94 Billion JPY 78.777%
Cytori Cell Research Institute, Inc. 5.81 Billion JPY 74.655%
AnGes, Inc. 28.89 Billion JPY 94.898%
OncoTherapy Science, Inc. 867.27 Million JPY -69.975%
Nxera Pharma Co., Ltd. 157.19 Billion JPY 99.062%
Immuno-Biological Laboratories Co., Ltd. 1.61 Billion JPY 8.923%
NanoCarrier Co., Ltd. 5.07 Billion JPY 70.931%
Carna Biosciences, Inc. 4.34 Billion JPY 66.111%
CanBas Co., Ltd. 2.43 Billion JPY 39.406%
D. Western Therapeutics Institute, Inc. 2.37 Billion JPY 37.888%
RaQualia Pharma Inc. 6.93 Billion JPY 78.729%
Chiome Bioscience Inc. 1.75 Billion JPY 15.833%
Kidswell Bio Corporation 5.08 Billion JPY 71.013%
PeptiDream Inc. 67.12 Billion JPY 97.804%
Oncolys BioPharma Inc. 2.04 Billion JPY 27.759%
Ribomic Inc. 3.54 Billion JPY 58.442%
SanBio Company Limited 5.04 Billion JPY 70.793%
Healios K.K. 15.15 Billion JPY 90.273%
BrightPath Biotherapeutics Co., Ltd. 1.23 Billion JPY -19.825%
Kubota Pharmaceutical Holdings Co., Ltd. 3.01 Billion JPY 51.122%
StemRIM 9.08 Billion JPY 83.765%
CellSource Co., Ltd. 6.87 Billion JPY 78.573%
FunPep Company Limited 2.49 Billion JPY 40.824%
Kringle Pharma, Inc. 2.61 Billion JPY 43.706%
Stella Pharma Corporation 3.82 Billion JPY 61.416%
TMS Co., Ltd. 3.55 Billion JPY 58.53%
Noile-Immune Biotech Inc. 5.77 Billion JPY 74.491%
Cuorips Inc. 6.18 Billion JPY 76.165%
K Pharma,Inc. 3.31 Billion JPY 55.516%
Takara Bio Inc. 123.2 Billion JPY 98.804%
ReproCELL Incorporated 9.05 Billion JPY 83.716%
PhoenixBio Co., Ltd. 2.71 Billion JPY 45.71%
StemCell Institute Inc. 6.54 Billion JPY 77.47%
Japan Tissue Engineering Co., Ltd. 6.98 Billion JPY 78.907%
CellSeed Inc. 2.46 Billion JPY 40.215%